<?xml version="1.0" encoding="UTF-8"?>
<p>In all, 65 of 69 patients enrolled in the study provided glasdegib plasma concentration data. Forty‐two patients were considered to be dose compliant and did not receive cytochrome P450 (CYP)3A4 inhibitors around the time of PK sampling (which might have influenced glasdegib exposure), and provided steady‐state 
 <italic>C</italic>
 <sub>trough</sub> parameter data on cycle 1 day 10. The observed glasdegib steady‐state 
 <italic>C</italic>
 <sub>trough</sub> geometric mean value was 308.7 ng/mL (geometric % coefficient of variance, 74%).
</p>
